NASDAQ · Biotechnology

ACHV (ACHV) Stock

$6.66 +2.94% NASDAQ: ACHV Healthcare

Valuation

MetricValue
Price$6.66
Market Cap$683.71M
P/E Ratio-4.63
P/B Ratio14.06
P/S Ratio0.00
EPS (TTM)$-1.25
52-Week High$6.92
52-Week Low$2.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-250.00%
ROA-130.95%
ROCE-250.00%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity1.40
Current Ratio4.44

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-33.0M$-41.0M$-27.0M$-39.0M$-55.0M
Net Profit$-33.0M$-42.0M$-30.0M$-40.0M$-55.0M
EPS$-4.05$-3.95$-1.50$-1.24$-1.25
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$48.0M$30.0M$19.0M$39.0M$42.0M
Total Liabilities$19.0M$22.0M$21.0M$18.0M$20.0M
Cash$43.0M$25.0M$16.0M$13.0M$21.0M
Borrowings$15.0M$16.0M$17.0M$10.0M$15.0M

Latest News

Achieve Life Sciences Stockholders Weigh Board Slate, Share Increase at Annual Meeting MarketBeat · Jul 10, 2026 Achieve Life Sciences Joins Russell 2000® Index GlobeNewswire · Jun 29, 2026 Achieve Life Sciences Receives FDA Complete Response Letter for Cytisinicline MT Newswires · Jun 22, 2026 Achieve Life Sciences Receives Complete Response Letter from FDA for Cytisinicline NDA GlobeNewswire · Jun 22, 2026 Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, MD to Board of Directors GlobeNewswire · Jun 2, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-29.0M$-38.0M$-24.0M$-30.0M$-49.0M
Investing Cash Flow$0$0$0$-22.0M$6.0M
Financing Cash Flow$0$0$0$1.0M$0
Net Cash Flow$7.0M$-18.0M$-9.0M$-3.0M$8.0M
Free Cash Flow$-29.0M$-38.0M$-24.0M$-30.0M$-49.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-17.42%
Quick Ratio2.62
Interest Coverage-55.00
Return 1Y126.01%
Return 3Y17.30%
Return 5Y-17.30%

Ownership

Insiders Held0.93%
Institutions Held63.63%
Institutions Float Held64.23%
Institutional HolderSharesReport Date
Franklin Resources, Inc.4,369,1932026-03-31
Propel Bio Management, LLC3,786,4252026-03-31
Vanguard Capital Management LLC2,204,7142026-03-31
Simplify Asset Management, Inc.1,184,5122026-03-31
Millennium Management Llc1,077,3382026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALLO $1.95 +2.63% -2.17 $673.05M 0.00%
ARCT $6.26 +0.64% -2.93 $177.93M 0.00%
AVIR $4.75 +1.06% -2.13 $380.13M 0.00%
CAPR $3.93 -5.76% -50.70 $227.59M 0.00%
HUMA $0.66 -1.79% -4.19 $110.81M 0.00%

About ACHV

ACHV is led by CEO Richard A. Stewart, employs 25 people, headquartered in CA, publicly traded since 1995.

ACHV stock trades at $6.66 with a market capitalization of $683.71M. The stock is valued at a price-to-earnings (P/E) ratio of -4.63, price-to-book of 14.06, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $2.00 and $6.92, and currently trades 3.8% below its 52-week high.

On profitability, ACHV generates a return on equity (ROE) of -250.00%, return on capital employed of -250.00%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides